Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
459
-
Total 13F shares, excl. options
-
44.1M
-
Shares change
-
-1.1M
-
Total reported value, excl. options
-
$9.73B
-
Value change
-
-$249M
-
Put/Call ratio
-
0.78
-
Number of buys
-
227
-
Number of sells
-
-229
-
Price
-
$220.75
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2023
561 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2023.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 459 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 44.1M shares
of 44.8M outstanding shares and own 98.38% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.1M shares), WELLINGTON MANAGEMENT GROUP LLP (4.69M shares), VANGUARD GROUP INC (4.64M shares), Avoro Capital Advisors LLC (2.91M shares), FMR LLC (2.62M shares), RENAISSANCE TECHNOLOGIES LLC (2.19M shares), STATE STREET CORP (1.88M shares), JANUS HENDERSON GROUP PLC (879K shares), GEODE CAPITAL MANAGEMENT, LLC (806K shares), and Palo Alto Investors LP (628K shares).
This table shows the top 459 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.